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Abstract In this work molecular modeling was applied to
generate homology models of the pore region of the Nav1.2
and Nav1.8 isoforms of human voltage-gated sodium chan-
nels. The models represent the channels in the resting,
open, and fast-inactivated states. The transmembrane por-
tions of the channels were based on the equivalent domains
of the closed and open conformation potassium channels
KcsA and MthK, respectively. The critical selectivity loops
were modeled using a structural template identified by a
novel 3D-search technique and subsequently merged with
the transmembrane portions. The resulting draft models
were used to study the differences of tetrodotoxin binding
to the tetrodotoxin-sensitive Nav1.2 (EC50: 0.012 μM) and
-insensitive Nav1.8 (EC50: 60 μM) isoforms, respectively.
Furthermore, we investigated binding of the local anes-
thetic tetracaine to Nav1.8 (EC50: 12.5 μM) in resting,
conducting, and fast-inactivated state. In accordance with
experimental mutagenesis studies, computational docking
of tetrodotoxin and tetracaine provided (1) a description of
site 1 toxin and local anesthetic binding sites in voltage-
gated sodium channels. (2) A rationale for site 1 toxin-
sensitivity versus -insensitivity in atomic detail involving
interactions of the Nav1.2 residues F385-I and W943-II. (3)
A working hypothesis of interactions between Nav1.8 in
different conformational states and the local anesthetic
tetracaine.
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Introduction
Human voltage-gated sodium channels are large multido-
main complexes comprising high sequence similarity [1,
2]. Their α-subunits, which form the ion-permeation pore
are responsible for ion-channel gating and the selective
permeation of Na+ ions. The long polypeptide chain folds
into four non-identical domains (I to IV) [3], each of which
is composed of six transmembrane α-helices (S1 to S6).
The permeation pore is positioned at the extracellular side
of the cell membrane and is formed by S5 and S6, linked by
P-loops. The latter fold partly back into the membrane to
form the so-called outer vestibule. This hosts the selectivity
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filter (DEKA-motif), which comprises four different
amino-acid side chains, one from each domain: aspartic
acid (I), glutamic acid (II), lysine (III), and alanine (IV).
The same P-loops shape the binding site for site 1 toxins,
such as tetrodotoxin (TTX), involving in each domain the
selectivity filter residue and its three C-terminal neighbors
(Fig. 1). However, human isoforms of voltage-gated
sodium channels are either sensitive or resistant to TTX
block (Table 1) with a single amino-acid variation dis-
criminating between these two channel types (Fig. 1). If the
C-terminal neighbor of the selectivity filter aspartic acid in
domain I contains an aromatic side chain, the channel will
be effectively blocked by TTX, whereas in the case of a
serine or a cysteine the channels are less susceptible to
blockade by site 1 toxins (for a review refer to [1]).
Voltage-gated sodium channels may also be obstructed
by local anesthetics which, in contrast to site 1 toxins, enter
the ion-permeation pore from the intracellular side of the
channel and bind to residues of the so-called inner vestibule
[2]. High-affinity binding of local anesthetics to sodium
channels appears to occur largely, but not exclusively, to
the inactivated state and involves the residues of the S6
transmembrane helices [4–12]. In the fast-inactivated state,
the intracellular linker between domains III and IV acts as
the so-called inactivation gate [13]. It has been hypothe-
sized that this loop would fold into the open channel pore
during inactivation. Experimental studies have revealed
that a hydrophobic IFM-motif within this loop is essential
for fast inactivation to occur [14–16].
However, to date all efforts to determine experimentally
the 3D-structure of the ion-permeation pore of voltage-
gated sodium channels have failed. This prevents the many
experimental results for these channels being put into a
wider context to reveal interaction networks between
residues in spatial proximity to one other. One way to
approach this problem is to model the structure of a
voltage-gated sodium channel based on an experimental
structure for a related membrane-bound protein. Yet early
modeling efforts were hampered by the fact that no
experimental structures were available to guide these
experiments. Hence, modeling concentrated mainly on
identifying P-loop architectures that corresponded to
functional and mutagenesis data. Lipkind, Fozzard, and
coworkers published a model for the toxin binding site 1 of
the mammalian Nav1.4 isoform in which the P-loops were
β-hairpins [17, 18]. In contrast, Guy and Durell postulated
that the P-loops in sodium channels would form a α-helix-
turn motif, followed by an extended segment [19, 20]. The
first X-ray structures for KcsA and MthK [21–23] revealed
that the overall topology of the P-loops in potassium
channels was indeed similar to the one proposed by the
Guy and Durell model. But it remained unclear whether or
not the different selectivity filters in sodium and potassium
channels required a different P-loop topology as well. In
their most recent model, Lipkind and Fozzard postulated
that the P-loops in voltage-gated sodium channels adopted
the substructure of a αβ-arch, a α-helix-turn-β-strand,
rather than a α-helix-turn-coil motif [24]. In order to
include as many experimental data as possible, i.e.
interactions with the site 1 toxins tetrodotoxin and
saxitoxin, and to satisfy structural constraints imposed
from the KcsA template, their P-loops were placed
differently with respect to KcsA. Their toxin binding site
was wider outside and narrowed toward the selectivity
filter. Still, in their model the Cα atoms of the selectivity
filter locus were further apart from the axis of Na+
Fig. 1 The P-loop sequences of human voltage-gated sodium
channel isoforms Nav1.2 and Nav1.8. Identical residues are bold and
marked by an asterisk (“*”) in the consensus line. The amino acids
of the outer vestibule forming the toxin binding site 1 are shown
between pipes (“1”). The toxin binding site 1 differs in one position
only: F385-I in Nav1.2 and S357-I in Nav1.8, respectively. The
residues of the selectivity filter DEKA-locus represent the N-
terminal (left limit), the outer ring residues the C-terminal border
(right limit) of the outer vestibule
Table 1 Average estimated binding energies for ligand-channel
complexes, Eass, and EC50 values for tetrodotoxin (Nav1.2 and
Nav1.8) and tetracaine (Nav1.8)
Eass
[kJ mol−1]
EC50
[μM]
Nav1.2 Tetrodotoxin −84 0.012a
Nav1.8 Tetrodotoxin −97 60b
Closed Fast-
inactivated
Open
Eass
[kJ mol−1]
Eass
[kJ mol−1]
Eass
[kJ mol−1]
EC50
[μM]
Nav1.8 Tetracaine −c −99 −88 12.5d
aNoda et al. [46]
bAkopian et al. [47]
cNo valuable docking results obtained
dTJD unpublished results
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permeation than their corresponding partners in the potas-
sium channel structures. Nevertheless, the Lipkind and
Fozzard model allowed explaining both the access of
tetrodotoxin and saxitoxin to the DEKA-locus as well as
favorable interactions of these ligands with residues of the
so-called outer ring (EEMD-motif in position +3 of the
DEKA-locus, (Fig. 1) [24, 25]. Furthermore, their model
provided evidence for the permeation of larger organic
cations through sodium as compared to potassium channels
[25]. Recently, Tikhonov and Zhorov suggested a model
for the outer vestibule of Nav1.4 by shaping the binding site
around a rigid toxin ligand. The starting configuration of
the P-loops was as in the open conformation potassium
channel MthK [26]. The authors assumed strong structural
similarity between sodium and potassium channels, how-
ever, their model allowed retracing important interactions
with the site 1 toxins tetrodotoxin, saxitoxin, and μ-
conotoxin, respectively.
Despite these modeling efforts, only little is known
about the structural implications of site 1 toxin binding to
different sodium-channel isoforms, i.e. TTX-sensitive and
TTX-insensitive isoforms. This is even more the case for
modeling interactions of voltage-gated sodium channels
with local anesthetics. To our knowledge, a systematic
structural analysis of the interactions between local anes-
thetics and voltage-gated sodium channels considering the
structural dynamics of the channel protein has not been
carried out to date. To address these open questions, we
applied molecular modeling to generate model structures of
the pore regions of Nav1.2 and Nav1.8 in different
conformational and thus functional states. Our models
contain the binding sites for both site 1 toxins and local
anesthetics. In a first step, we computationally docked
tetrodotoxin to the TTX-sensitive Nav1.2 and the TTX-
resistant Nav1.8 isoforms and investigated the interactions
between the ligand and the receptor. Although the outer
vestibules of Nav1.2 and Nav1.8 differ in one amino acid
only (Fig. 1), this subtle difference suffices to affect their
binding activity toward TTX by ca. 5,000-fold (Table 1).
Similarly, the local anesthetic binding sites of the two
isoforms are almost identical but significant differences in
affinity toward tetracaine have not been reported so far. Not
surprisingly, computational docking of tetracaine to Nav1.2
and Nav1.8 in closed, open, and fast-inactivated confor-
mation yielded similar results.
Materials and methods
Modeling transmembrane segments
Using the Swiss PDB Viewer (SPDBV) environment [27]
the S5 and S6 transmembrane segments of Nav1.2 (Swiss-
Prot accession Q99250) and Nav1.8 (TrEMBL accession
Q9Y5Y9) were aligned to the corresponding M1 and M2
helices of KcsA (PDB code 1BL8 [23]) and MthK (PDB
code 1LNQ [21, 22]), respectively (Fig. 2). Alignment of
the S5 sequences onto M1 of KcsA and MthK was
anchored at a conserved glycine residue four positions
upstream of the C-terminal helix end. Also, in MthK and
almost all isoforms of sodium channels, a phenylalanine is
located at the C-terminus of M1 and S5, respectively. The
structural alignment of the S6 TM-helices was anchored at
a functionally important glycine residue for channel open-
ing, G99 in KcsA and G83 in MthK [21]. Additionally,
reported interactions between local anesthetics and resi-
dues of various mammalian sodium channel isoforms,
revealed by site-directed mutagenesis [4–12], were used to
align these residues such that they faced the ion permeation
pore wherever experimental data suggested so. For domain
II, no such interactions have been reported to date. There-
fore, the target to template alignment for S6-II was
anchored exclusively on the putative glycine hinge residue
G970 in Nav1.2 and G877 in Nav1.8 aligned with G99 of
KcsA and G83 of MthK, respectively. From the resulting
structural alignment model structures were generated for
four unconnected S5 and S6 helices each using the
homology modeling engine promodII [27].
Modeling P-loops
A suitable template structure for the P-loops was found by
searching a representative non-redundant set of 474 PDB-
files. The structures shared less than 35% sequence identity
and no fold similarity. The search query was programmed
applying a modified version of the SPDBV scripting lan-
guage. A search was performed to select fragments that
could be subsequently grafted onto the anchor residues of
the transmembrane helix bundle. To allow for adequate
search flexibility fragments were required to contain 12 to
16 residues of α-helix secondary structure followed by
either three to 13 coiled residues or three to seven coiled
residues and three to six residues of β-strand secondary
structure. The identified fragments were clustered within
SPDBVaccording to their rmsd value compared to the first
hit of the search. Each time the rmsd to any previously
defined cluster was above 2.0 Å a new cluster was created.
Representatives of each cluster were then inspected
manually for possible fitting onto the transmembrane
helix bundle, which was determined predominantly by
sterics. In order to fit onto the transmembrane helices the
loops were required to turn sharply between the N-terminal
α-helix and the C-terminus. Further selection criteria were
the overall space occupied by the loop, the orientation of
side chains, i.e. in the turn and C-terminus, and the
enthalpy of the resulting structure. In this way N523 to
Y544 of glutamine amidotransferase from E. coli (PDB
code 1MOQ [28]) was chosen as the best modeling tem-
plate. The 12 residues from N523 to E534 are α-helical,
followed by ten residues in coiled conformation from E535
to Y544. The sequence fragments of the P-loops were
aligned on the respective fragment of the 1MOQ template
and homology models built using promodII [27]. As a
result, four P-loop model structures, one for each domain,
were obtained. To validate our choice of P-loop template,
the template-selection step was carried out using trans-
membrane helix bundles from closed and open conforma-
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tion models. It was found that the extracellular region of the
transmembrane helices and P-loops vary only slightly in
the two conformations and that major rearrangements
occur predominantly in the cytosolic part. As a conse-
quence, these minor structural variations in the P-loop
region did not affect our choice of template (data not
shown).
Assembling fragments
The four P-loop models were placed manually on top of the
transmembrane helices guided by the positions of both
these helices and the P-loops in KcsA and MthK, re-
spectively (Fig. 3). Steric clashes between fragments were
removed through manual manipulation and the enthalpy of
the model structures was minimized during two by 200
steps of Steepest Descent simulations using the GRO-
MOS96 force field [29] as implemented in SPDBV [27].
Fast-inactivated form The inactivation gate substructure
was placed manually to the open state model using the
NMR-structure of a 21-residue fragment of the rat brain
channel II (PDB code 1BYY [30]). Its position in the
structure reflects the most prominent interactions of
inactivation gate residues, i.e. I1433 and F1434, as well
as residues of S6-IV, i.e. F1710 and Y1717 (numbering
according to Nav1.8). Potential clashes between residues
were identified in SPDBV and removed applying energy
minimization as described in the general protocol.
Fig. 2 Domain-separated mul-
tiple sequence alignment of the
S5 and S6 helices of human
Nav1.2 and Nav1.8 to the M1
and M2 transmembrane helices
of the KcsA and MthK tem-
plates. Identical residues be-
tween the two sodium channel
isoforms are bold and marked
by an asterisk (“*”) in the
consensus line. Sequence num-
bering is according to Nav1.8.
Filled squares indicate residues
involved in sodium channel ac-
tivation. Open squares highlight
positions that were experimen-
tally found to interact with local
anesthetics. In our models, res-
idues aligned to black dots form
the local anesthetic binding site.
Open circles represent the posi-
tions of the gating hinge glycine
residues in MthK as found by
Jiang et al. [21, 22]
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Structure validation
To validate the quality of the resulting model structures, a
two-fold strategy was followed. Firstly, the models were
investigated for structural errors. Within the SPDBV
environment, checks for clashes between residues were
performed and potentially high enthalpy values detected
[27]. In addition, PROCHECK [31] was used for a more
detailed assessment of the model quality. Secondly, the
resulting model structures were required to satisfy available
biochemical knowledge, i.e. functional information, muta-
genesis data, and interactions with site 1 toxins and local
anesthetics.
Docking of site 1 toxins and local anesthetics
Computational docking of tetrodotoxin and tetracaine was
performed using the FLO software [32], which allows for
flexibility in both the ligand and the protein. The region
including the selectivity filter and the outer and inner
vestibule was used as the docking target and free movement
around the residues lining these pockets was allowed. For
each of the ligands, 500 Monte Carlo searches were
performed applying a FLO force field modified to re-
produce correctly the torsional preferences for the tetracaine
di-ortho aryl-amide bond (orthogonal). The ten best scoring
results from FLO were selected and investigated further.
Results
Defining restraints to model the toxin binding site 1
Prior to the model-generation step, biochemical and
mutagenesis data were collected for Nav1.2, Nav1.8 and
other isoforms of mammalian voltage-gated sodium
channels. In an approach similar to pharmacophore mod-
eling, these data were translated into geometrical and
physico-chemical constraints, which the resulting models
had to satisfy (Fig. 3). Firstly, the dimensions of tetrodo-
toxin (max. 7.5 Å along and 9.4 Å perpendicular to the
membrane axis; Fig. 3a) and its interactions with the
channel protein [17–20, 24, 26, 33] determined the shape
and size of the outer vestibule. From this it was concluded
that the selectivity filter and outer ring residues in the same
domain had to be separated by ca. 9-10 Å (Cα distance).
Accordingly, opposite residues of the outer ring EEMD-
locus (Fig. 1) were expected to be ca. 10–12 Å apart (Cα
distance ca. 15.8 Å) (see below). Secondly, at its narrowest
point the selectivity filter ought to allow dehydrated Na+ to
pass. Therefore, the ionic radius of Na+ determined the
minimal distance between the side chains of the DEKA-
Fig. 3 Modeling the assembly of P-loops and transmembrane
part of Nav1.2 and Nav1.8 was based on geometrical restraints.
(a) Maximum expansion of tetrodotoxin. The distance d=7.50 Å
represents the distance between the two hydroxyl groups of C4
and C10. d=9.40 Å is the distance between NH of the 1,2,3-
guanidinium group and the C11 hydroxyl [48]. Tetrodotoxin is
in CPK representation and colored by atom type. (b) Diameter
of an octahedrally coordinated Na+ ion [49]. Although the exact
coordination number of Na+ in the selectivity filter of voltage-
gated sodium channels remains unclear, a six-fold octahedral
coordination was assumed following the work of Allen et al.
[50]. (c) Closest Cα–Cα and overall distance between S5-I
(pink) and S6-II (blue). S6-I and S5-II are also displayed and
colored in gray. This restraint limits the expansion of the P-loop
substructure as well as its orientation when placed onto the
transmembrane helices. (d) Position of the P-loop between S5-I
(pink) and S6-II (blue). (e) The models contain two ligand
binding sites. The binding site for site 1 toxins is located
extracellular (top) to the selectivity filter (central plane), whereas
the local anesthetic binding site is toward the cytosol (bottom).
The top and bottom planes sketch the limits of both binding
sites. For reasons of simplicity, the channel model is represented
by two opposite domains with the S5-helices in pink, S6 in
blue, and the P-loops in gray
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locus (Fig. 3b) leading to a Cα distance of opposite DEKA
residues of ca. 10.5 Å. Thirdly, the most membrane-
oriented selectivity filter residues T75 and T59 in KcsA
and MthK, respectively, determined how deep the sodium
channel P-loops would fold back into the membrane, since
the residues of the DEKA-locus were structurally aligned
to them. As a consequence, the TTX binding site was to
adopt a slightly confined shape, being ca. 5 Å wider at the
outer ring (Cα-distances) than at the selectivity filter
(Fig. 3e). Finally, in the assembled structure, each P-loop
fits into a cleft between S5 and S6 of neighboring domains
(Fig. 3d) [21–24]. The closest Cα contacts between these
helices were ca. 12-13 Å, which impaired what shape and
horizontal extension any potential P-loop might adopt
(Fig. 3c). Moreover, this cleft played an important role in
placing the P-loops within the structural ensemble, as it
determines the width of the Na+ permeation pore at the
DEKA-locus within the structural ensemble.
Modeling the toxin binding site 1 in Nav1.8
and Nav1.2
Numerous mutagenesis experiments revealed that the
selectivity filter differs among sodium and potassium
channels [2, 34–41]. Potassium channels are homo-tetra-
meric and their selectivity filter is formed by the backbone
carbonyl oxygens of four identical TVGY repeats. In
contrast, in the hetero-tetrameric voltage-gated sodium
channels the side chain of only one residue per domain
contributes to the selectivity filter (DEKA-motif). In order
to make room for these side chains the Cα-atoms of the
DEKA-locus residues were placed farther apart compared
to the potassium channel templates. But, if the size of the
Na+ permeation pore at the DEKA-locus increases the less
space will be available for the P-loops without interfering
with the transmembrane helices. By comparing the
experimental KcsA (closed) and MthK (open) potassium
channel structures it was found that these channels undergo
substantial conformational rearrangement in the cytosolic
region, but not in vicinity to the P-loops leading to the
conclusion that the pore structure close to the P-loops in
potassium and thus most likely also in sodium channels is
well conserved. Therefore, we systematically searched the
known structure space for potential P-loop templates that
would allow a widening of the pore at the DEKA-locus
while still fitting into the space provided by the rather
invariant transmembrane helices. It is generally accepted
that the N-terminal part of sodium channel P-loops ought to
be α-helical [19, 20, 24, 26]. Whereas this restricted our
search at the N-terminus, we remained flexible with respect
to the C-terminal part. Interestingly, the most suitable P-
loop template was similar to the one proposed by Guy and
Durell, an α-helix followed by a turn and an extended
region [19, 20]. In this fragment the α-helix was followed
by a sharp turn which in our models allowed indeed the
toxin binding site to widen toward the outer ring, despite an
increased Cα distance of the selectivity filter residues. The
presence of the side chains of DEKA, however, would
impair that the gap for Na+ to pass may not be larger than
ca. 2.5 Å times 2.5 Å, after displacement of i.e. the large
lysine side chain.
In voltage-gated sodium channels in position +2 of the
DEKA-locus a conserved tryptophan is found in domains I,
III, and IV. Yet in domain II, this tryptophan is in position
+1 (Fig. 1). In our models the side chains of the tryptophans
in domains I, III, and IV pointed toward the P-loop α-helix
of their clockwise neighbor domain (II, IV and I, re-
spectively) delimiting the outer vestibule and therefore the
toxin binding site. In domain II the tryptophan was oriented
toward the P-loop of domain I (counterclockwise) and was
more exposed toward a potential ligand. In absence of a
tryptophan in position +2 of domain II, the outer vestibule
between domains II and III was confined by an isoleucine
in position +2 of domain II and a methionine in +3 of
domain III.
Docking of site 1 toxins to Nav1.2 and Nav1.8
It is well known that mutating the C-terminal neighbor of
the domain I selectivity filter aspartic acid results in a 5000-
fold difference in binding affinity of the TTX-sensitive
Nav1.2 and the TTX-insensitive Nav1.8 isoforms to te-
trodotoxin (Table 1). To determine the mode of interaction
with either isoform TTX was computationally docked to
Nav1.2 and Nav1.8 allowing flexibility in both the ligand
and the protein. In both cases attractive electrostatic
interactions were observed due to the formation of a salt
bridge of the 1,2,3-guanidinium group of tetrodotoxin to
the selectivity filter aspartic and glutamic acid in domain I
and II. Moreover, the position of the ligand in the binding
pocket was further stabilized by forming hydrogen bonds
to the outer ring residues, i.e. E387-I in Nav1.2 (E359-I in
Nav1.8), E945-II (E852-II), and D1717-IV (D1664-IV).
These interactions corresponded to earlier findings by other
groups [24–26] but were insufficient to explain the much
lower EC50 value of Nav1.2 toward TTX. However, when
steric interactions were considered a striking difference in
ligand binding to the two isoforms could be observed. For
Nav1.2, steric interactions of the ligand with (hydrophobic)
binding site residues were predominantly through contacts
with F385-I and W943-II. The side chains of both residues
formed a “V” to which the 1,2,3-guanidinium group of
TTX fit perfectly, besides its interaction with the selectivity
filter and outer ring residues (Fig. 4). This interaction may
not only be steric, but may also include a cation-π in-
teraction between the guanidinium group and the aromatic
moieties of either W943-II or F385-I [42]. As a
consequence, for Nav1.2 only one binding conformation
of TTX with limited translational freedom in the binding
site was observed. In contrast, in Nav1.8 this “V”-shaped
substructure was not found. Instead, the serine 357-I side
chain left a void next to W850-II (Fig. 4) and the docked
ligand appeared much more flexible in the binding site
corresponding with a lower binding energy, Eass (Table 1).
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Local-anesthetic binding site
The local-anesthetic binding site of voltage-gated sodium
channels is located intracellular of the selectivity filter in
the transmembrane part of the channel. The selectivity filter
residues (DEKA) and their N-terminal neighbors (QGFS)
form the extracellular limit of this binding site and prevent
local anesthetics from diffusing through the membrane.
From the selectivity filter, the local anesthetic binding site
extends through the membrane and is composed of residues
of the transmembrane helices S6, i.e. the residues that face
the pore at the four helix turns that follow the selectivity
filter intracellularly (Fig. 2). At the third helix turn, the side
chains of two rather than one amino acid face the pore in all
four domains. Altogether, the local anesthetic binding site
consists of 28 highly conserved amino acids (see Electronic
Supplementary Material). Sequence variation of the pore
lining residues in the two isoforms was rare and subtle
(I417-I, S1461-III and L1768-IV in Nav1.2 vs. V389-I,
G1406-III and V1714 in Nav1.8) (Fig. 2). Interestingly, in
the position of the hinge residue in domain IV is a serine in
both isoforms compared to a glycine in domains I, II and III
and the potassium channel structures KcsA and MthK.
Docking of local anesthetics
Local anesthetics interact preferably with voltage-gated
sodium channels in the fast-inactivated state [43]. Howev-
er, they can also act on the active state and may even be
trapped in the closed form [44]. In order to study the
molecular basis of these observations tetracaine was
docked to the local anesthetic binding site of Nav1.8 in
closed, open, and fast-inactivated conformation. It was
observed that the charged amine of the ligand formed
hydrogen bonds with the selectivity filter residues aspartic
and glutamic acid of domain I and II, whereas the aromatic
moiety of the ligand pointed toward the cytosol (Fig. 5).
Whereas binding of the polar head group to the selectivity
filter remained unaffected by the conformational state of
the channel interactions of the channel protein with the
aromatic moiety varied greatly.
Docking of the rather large tetracaine to Nav1.8 in the
closed conformation was highly unfavorable. In particular,
the local anesthetic binding site narrowed toward the
cytosol leaving not enough space to host the voluminous
substituted aromatic part of the ligand. As a consequence,
docking artifacts were observed where the ligand adopted
an alternative conformation (Table 1). In this case, the
aromatic moiety tended to leave the inner vestibule through
an opening between the S6-helices of neighboring domains
Fig. 4 Interaction of tetrodotoxin with the TTX-sensitive voltage-
gated sodium channel isoform Nav1.2 (left) and the TTX-insensitive
Nav1.8 (right) seen along (top) and perpendicular (bottom) to the
membrane axis. The DEKA-filter residues as well as W943-II in
Nav1.2 and W850-II in Nav1.8 are represented in CPK and colored
according to type: blue=basic, red=acidic, gray=hydrophobic. F385-
I in Nav1.2 and S357-I in Nav1.8 are shown in CPK and are colored
pink. Yellow circles indicate the regions where the positions of the
ligand in the binding site are most different. Top center: position of
the site 1 toxin binding site in the structural models as seen along the
axis of the membrane. Top left: the selectivity filter A1714-IV as
well as F385-I are hidden behind the ligand. Yellow circles indicate
the orientation of the guanidinium group of the ligand as well as the
position of W943-II in the binding site. Top right: the selectivity
filter A1661-IV and S357-I are located behind the ligand. The
guanidinium group of TTX has rotated ca. 90° in the binding site
due to the changed position of W850-II. Bottom left: the yellow
circle highlights the “V”-shape between F385-I and W943-II to
which tetrodotoxin closely fits. Bottom right: The side chain of
W850-II is in a different position than in Nav1.2
Fig. 5 Tetracaine in complex with Nav1.8 in fast-inactivated form.
The ligand is represented in CPK and colored by atom type.
Ribbons and amino acids are colored by domain: yellow=domain I,
blue=domain II, green=domain III, red=domain IV, pink=in-
activation gate. Main interaction partners are shown in CPK.
(a) Tetracaine bound to the inner vestibule. View along the
membrane plane. (b) Same view as in a but limited tomain interaction
partners only. The polar head group of tetracaine interacts with the
DEKA-motif residues, its hydrophobic tail with the hydrophobic and
mainly aromatic residues of S6-IV and the inactivation gate
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in the direction of the membrane. However, the binding site
is large enough to trap smaller organic molecules and even
small local anesthetic drugs (data not shown). In contrast,
tetracaine docking to the open and in particular to the fast-
inactivated form yielded substantially better energy values.
As for the closed form, the charged amino group formed
hydrogen bonds to either aspartic or glutamic acid of the
selectivity filter. But in the models representing the fast-
inactivated form the inactivation gate structure blocked
access to the inner vestibule and exposed the conserved
IFM-motif to the ligand (Fig. 5). Hence, tetracaine was
surrounded entirely by residues of the sodium channel and,
as a consequence, ligand movement within the binding site
was substantially confined. Docking of tetracaine to the
fast-inactivated form was energetically most favorable
(Table 1). It is suggested that the energy difference com-
pared to docking to the open conformation model was due
to the presence of interactions which trapped the ligand
sterically in a predominantly hydrophobic binding site.
Common main interactions of the ligand occurred mainly
with F1710-IVand the inactivation gate residue F1434 and
to a lesser extend with Y1717-IV and I1433 corresponding
to interactions reported for local anesthetics with other
sodium channel isoforms [11, 12]. Furthermore, tetracaine
formed a H-bond to the conserved N1411 in the third helix
turn of S6-III. We postulate that in the presence of
tetracaine water may be largely excluded from the inner
vestibule of the fast-inactivated channel. However, we
consider it possible that a few water molecules may be
present close to the selectivity filter where interactions
between the ligand and the channel are predominantly
polar. Additionally, the opening between the S6-helices
may host several water molecules.
Discussion
What does the outer vestibule look like?
It has long been assumed that the different nature and
composition of the selectivity filters in sodium and po-
tassium channels would have resulted in differently shaped
3D structures around the selectivity filter [1]. In the
absence of experimental structures for voltage-gated sodi-
um channels it was attempted to predict the structure of the
outer vestibule including the selectivity filter [17–20, 24,
26, 33]. However, the resulting models were not unambig-
uous with respect to the topology of the individual P-loops
and with respect to how the four P-loops assembled to form
the toxin binding site 1. It is accepted that, as in potassium
channels, the N-terminal part of the sodium channel P-
loops is α-helical [19, 20, 24, 26]. Yet these models differ
in the secondary structure following the α-helix-turn.
Lipkind and Fozzard believed that the α-helix-turn was
followed by a β-strand (αβ-arch) [24], whereas Guy and
Durell suggested several residues in coil conformation [19,
20]. However, both groups postulated that the backbone
atoms in the sodium channel P-loops had to be further apart
from each other than in potassium channels to make room
for the side chains of the selectivity filter residues. This
displacement would lead to clashes between residues of the
S5 and S6 transmembrane helices and the P-loop. In order
to avoid such unfavorable interactions, the P-loops in the
Lipkind and Fozzard model were twisted compared to the
KcsA template. Nevertheless, both models allowed ra-
tionalizing mutagenesis data and retracing important
interactions of voltage-gated sodium channels with i.e.
tetrodotoxin and saxitoxin [19, 20, 25]. Recently, Tikhonov
and Zhorov built models for the P-loops of Nav1.4 by
shaping the binding site around rigid molecules of
tetrodotoxin, saxitoxin and μ-conotoxin by means of
Monte-Carlo minimization [26]. Their approach was
interesting, since in the starting conformation the P-loops
were placed as in the MthK structure. In their models, the
solution structures for the outer vestibule were highly
similar and thus independent from the simulated toxin. This
indicates that the binding site for at least smaller site 1
toxins, such as tetrodotoxin and saxitoxin, is rather rigid.
Moreover, it is common to all models that the toxin binding
site of voltage-gated sodium channels is most likely to be
confined at the DEKA-locus and opens toward the outer
ring [19, 20, 24, 26]. Evidently, interactions with toxins
require that key amino acids be placed at specific positions
in space, allowing for certain flexibility in the topology and
the arrangement of the P-loops to one another.
One open question remains the order of secondary
structure for the amino acids following the turn at the
selectivity filter. Our models and earlier work give
evidence that this may be of no higher order [19, 20, 26].
This is supported by the fact that the positions of the C-
terminal part of the P-loops were affected during Monte-
Carlo simulations [26]. Higher order secondary structure
might either limit such displacement or would break down
in order to preserve favorable interactions with the ligand.
Additionally, in this work a systematic search of the PDB
for suitable fragments yielded as the best result a α-helix-
turn motif succeeded by residues in coiled conformation.
A second open question addresses the position of the
DEKA-locus with respect to the potassium-channel
structures. Tikhonov and Zhorov postulated a minimally
wider pore at the selectivity filter compared to the
potassium channels, whereas in our models the P-loops
were even more open at the DEKA-locus. From an
evolutionary viewpoint it might be advantageous if only
one selectivity filter architecture had evolved and existed
with minor structural and thus functional modification in
several cation channel families. However, the more similar
the DEKA-locus to the selectivity filter of potassium
channels, the more difficult the correct orientation of the
side chains. In the model by Tikhonov and Zhorov, the side
chains of the selectivity filter aspartic acid and alanine do
not face the pore due to sterical restrictions. On the
contrary, in our models the side chains of all four DEKA
residues faced the pore, but the wider pore made it
necessary to rearrange the positions of the P-loops in order
to avoid clashes with the transmembrane helices.
Our models for Nav1.2 and Nav1.8 were accurate enough
to comprehend biochemical and mutagenesis data and to
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study isoform-specific interactions with tetrodotoxin for
the first time (see below).
Sensitivity versus insensitivity toward site 1 toxins
Varying the C-terminal neighbor of the selectivity filter as-
partic acid in domain I determines whether a voltage-
gated sodium channel is sensitive or insensitive to block by
tetrodotoxin [2, 34, 35–41]. In this work, computational
docking of TTX to the TTX-sensitive Nav1.2 and TTX-in-
sensitive Nav1.8 sodium channel isoforms was performed.
Besides the known attractive electrostatic interactions be-
tween the 1,2,3-guanidinium group and the hydroxyl
groups of TTX and the acidic residues of the selectivity
filter and the outer ring, respectively [17, 24–26], a steric
component was discovered including the C-terminal neigh-
bor of the DEKA-motif aspartic acid and a conserved tryp-
tophan of domain II. Remarkably, in domains I, III, and IV
a tryptophan is conserved in position +2 of the selectivity
filter. In our models, the side chains of these residues were
oriented toward the α-helix of the same domain capping
the gap between the P-loops of domains II, IV, and I, re-
spectively. In domain II, the conserved tryptophan is in
position +1 of the selectivity filter glutamate and its side
chain is oriented toward the domain I rather than the do-
main III P-loop. As a result, the outer vestibule between
domains II and III was not limited by a tryptophan but by
the isoleucine in position +2 of domain II and by the
methionine in position +3 of domain III of the respective
selectivity filter residues. It is worth noting that the outer
vestibule and thus the binding site for type 1 toxins is
asymmetric setting voltage-gated sodium channels apart
from the four-fold symmetric potassium channels. In
Nav1.2, the side chains of W943-II and F385-I came close
to each other forming a “V” to which the 1,2,3-guanidinium
group of TTX could fit tightly (Fig. 4). Observed inter-
actions of both residues with the ligand were predomi-
nantly steric, but we postulate also cation-π interactions
between the 1,2,3-guanidinium group and the aromatic side
chains [42]. In Nav1.8, the “V”-pocket did not exist. Here,
the smaller and more flexible serine side chain in position
357-I created a void compared to Nav1.2 and allowed for
increased flexibility of both the ligand and the protein in
this region (Fig. 4). We strongly assume that the observed
interactions do apply for other isoforms as well. Therefore,
effective binding of TTX and other site 1 toxins (data not
shown) would only occur when the aromatic neighbor of
the domain I selectivity filter residue interacted closely with
the tryptophan in domain II. This aromatic residue may
either be a phenylalanine (Nav1.1, Nav1.2) or a tyrosine
(Nav1.3, Nav1.4, Nav1.6, Nav1.7). In the case of a tyrosine
we do not rule out the formation of an additional hydrogen
bond between the hydroxyl group of the tyrosine and the
ligand (data not shown). In contrast, if this residue was
aliphatic (cysteine in Nav1.5, serine in Nav1.8 and Nav1.9)
the sterical component of interaction with the ligand was
less pronounced and binding less unambiguous resulting in
a significantly lower binding affinity.
Binding of local anesthetics to Nav1.8 in different
conformational states
This work represents the first attempt to investigate in silico
the binding of local anesthetics to a voltage-gated sodium
channel in different conformational states. We chose
tetracaine as a test compound, because the binding affinity
of Nav1.8 toward tetracaine was in the same low μmolar
range (Table 1), common to many local anesthetics (http://
www.iuphar-db.org/iuphar-ic/sodium.html). Our docking
experiments revealed that tetracaine interacted most
favorably with the open conformation channel, which
was blocked by the inactivation gate. Upon occlusion of
the local anesthetic binding site by the inactivation gate
tetracaine was trapped inside the channel leaving its
hydrophobic moiety exposed to a predominantly hydro-
phobic environment. Besides hydrogen bonding of the
polar head group with D356-I and E849-II of the selectivity
filter, main interactions occurred with the S6-IV helix
residues F1710 and Y1717 as well as with I1433 and
F1434 of the inactivation gate, residues which were
described earlier as being essential for local anesthetics
binding (for an overview [11, 12]). The ligand was
additionally stabilized in this position by forming an H-
bond to N1411-III, a residue found to affect the binding of
local anesthetics in rat Nav1.2 [12]. When docked to the
open conformation model, the polar interactions between
the tetracaine head group and the DEKA-locus were
preserved. However, the non-polar aromatic moiety was
less tightly bound to the local anesthetic binding site and in
vitro would have, at least partly, been exposed to water.
Our docking studies also indicated that the local anesthetic
binding site might be large enough to allow binding of
smaller drugs, such as lidocaine and etidocaine, to the
closed channel as well (data not shown). In this case it
might be possible that local anesthetics with higher binding
affinity might not be released from the binding site when
the channel transforms from the fast-inactivated to the
resting state as suggested by Vedantham and Cannon [44].
On the contrary, the size and chemical nature of tetracaine
may not be exceeded without affecting the position of the
inactivation gate and thus the closure of the ion permeation
pore. If the ligand was larger or more rigid, i.e. by
substitutions in the aromatic moiety, the inactivation gate
might not be able to close, at least not completely. This
hypothesis is in line with earlier observations for larger
local anesthetic drugs, which block ion permeation in the
open but not in the fast-inactivated state (for an overview
[45]).
Limitations of the models
The models presented here are useful working models to
study the principles of sodium channel gating and
biochemical function. In the absence of experimental 3D-
structures such draft models are powerful tools to
rationalize and plan mutagenesis experiments (including
disease-associated single amino acid polymorphisms) and
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biochemical studies of voltage-gated sodium channels.
However, the accuracy of these models is inferior to that of
experimentally determined structures, affecting the inter-
pretation of structural and docking studies. Hence,
although our docking studies reveal interesting insights
into possible interactions between ligands and the channel
protein, which are in line with experimental results, they
remain hypothetical until backed up by experimental 3D-
structures.
Conclusions
We presented a series of structural models for the human
voltage-gated sodium channels Nav1.2 and Nav1.8 in
resting, active, and fast-inactivated state. It was postulated
that binding of tetrodotoxin occurred via attractive polar
interactions with the selectivity filter residues of domain I
and II as well as with the residues of the outer ring.
However, sensitivity toward tetrodotoxin depends on the
tightness of binding. In sodium channels sensitive to
tetrodotoxin block, the aromatic side chains of the C-
terminal neighbors of the selectivity filter residues in
domains I and II formed a “V”-like structural motif to
which the ligand could bind favorably. In toxin-insensitive
channel isoforms this “V”-substructure does not exist and
binding of tetrodotoxin was less preferred corresponding to
experimentally determined binding affinities. Moreover,
we developed for the first time a picture of the local
anesthetic binding site of voltage-gated sodium channels
taking into account all experimental findings concerning
local anesthetic block, activation, and interactions with the
inactivation gate. We were able to postulate the residues
that contribute to the local anesthetic binding site,
including those residues which interact only weakly with
ligands.
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